GLAXOSMITHKLINE PLC - ADR (GSK)

CUSIP: 37733W105

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / ADR
Total 13F shares
824,648
Share change
-62,481
Total reported value
$31,946,441
Price per share
$38.74
Number of holders
6
Value change
-$2,420,481
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 37733W105?
CUSIP 37733W105 identifies GSK - GLAXOSMITHKLINE PLC - ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q1 2025

As of 31 Mar 2025, GLAXOSMITHKLINE PLC - ADR (GSK) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 824,648 shares. The largest 6 holders included KAHN BROTHERS GROUP INC, PARADIGM ASSET MANAGEMENT CO LLC, PARK CIRCLE Co, Asset Planning,Inc, Byrne Asset Management LLC, and HUNTINGTON NATIONAL BANK. This page lists 6 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.